Articles from Benzinga

Facebook and Instagram users may be looking to leave over the company's new content moderation policies, which have shown some questionable timing in recent weeks.

The Benzinga Stock Whisper Index highlights five stocks that saw increased interest from readers during the week.

Cathie Wood, CEO of Ark Invest, on Thursday addressed the recent launch of Trump Coin (CRYPTO: TRUMP) and her views on the broader crypto market.

MicroStrategy plans to redeem $1.05B of convertible notes due 2027 with Class A common stock, aligning with its Bitcoin-focused strategy.

Wall Street paused for a breather on Friday, with the S&P 500 index hovering around the flatline at midday trading in New York after a five-day rally that pushed the market to fresh record highs this week. Meanwhile, investor attention shifted to forex and gold markets.

Goldman Sachs analyst cuts ExxonMobil price forecast due to mark-to-market commodity prices, but maintains Neutral rating. Q4 earnings expected on Jan 31, 2025.

Wall Street raised SLM's price targets after Q4 earnings release. EPS missed, but fiscal 2025 outlook higher than estimates. Analysts maintain ratings.

Thornburg Investment Management launched its first two international equity ETFs with a focus on developed markets. Active management and low fees.

Massive wildfires in LA have caused financial damage of $35-45 billion, affecting homeowners and insurance companies. Stocks to sell/avoid for now.

Calamos Investments has introduced a suite of Protected Bitcoin Exchange-Traded Funds (ETFs), designed to offer exposure to Bitcoin (CRYPTO: BTC) while minimizing risk.

Chinese EV makers BYD, Geely, and SAIC contested EU's import duties at Court of Justice. Tesla excluded from tariffs, gaining only 7.8% tax.

Economist and commentator Peter Schiff on Friday sharply criticized President Donald Trump‘s recent executive order on digital assets, suggesting it is a thinly veiled attempt to “pay off donors” rather than a genuine effort to

Trump Meme Coin launch raises concerns For Crypto's future - see why

AT&T (T) reports Q4 earnings on Monday. Expectations: EPS $0.50, revenues $32.04B. Stock up 36% in past year, bullish trend continues. Analysts see 22% upside, price target $23.52.

Analysts lower price forecast for FCX after Q4 results, with JP Morgan reiterating $48 target and Neutral rating. Sales fell short of estimates.

Raymond James analyst Savanthi Syth lowered American Airlines' price target from $24 to $23, citing FY25 1Q guidance misses due to higher fuel prices and capacity issues. Despite challenges, the company's favorable CASM-ex trend for 2025 and a strong free cash flow outlook above $2B support its recovery.

SoFi (SOFI) reports Q4 earnings on Monday with expected EPS of 4 cents and revenue of $674.13 million. Stock is up 28.91% YTD. Analysts see 29% downside potential for stock with current consensus rating of Buy and price target of $10.33.

Allurion Technologies (NYSEALUR) shares are moving higher Friday potentially after after the company announced plans to conduct a clinical study evaluating the combination of its Allurion Program with GLP-1 agonists on Thursday.

The FolioBeyond Enhanced Fixed Income Premium ETF offers innovative strategies for diversification and income generation with a focus on risk-adjusted returns.

Despite concerns about iPhone demand, analyst remains bullish on Apple's earnings potential. Services growth and margins keep outlook positive.

TransCode Therapeutics Inc. (NASDAQRNAZ) shares are moving higher Friday after the company announced that the first patient in Cohort 3 of its Phase 1 clinical trial has been dosed with its lead candidate, TTX-MC138 on Tuesday.

A new poll reveals whether investors think Warren Buffett will sell more Apple stock on the heels of China iPhone demand concerns.

Goldman Sachs analyst optimistic about cruise line industry after successful Q3. Royal Caribbean and Norwegian Cruise Line ratings and price targets lowered.

NVIDIA shares are moving lower on Friday following soft guidance from Texas Instruments.

Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved investor sentiment likely.

NextEra Energy reports Q4 results, with revenue missing estimate. Expects continued growth and dividend increases through 2027.

Stock market rally faces reality check as equity risk premium turns negative, sparking debates about potential overvaluation and potential echoes of dot-com bubble.

TikTok's fate remains uncertain as Apple, Google, and Oracle have differing approaches due to their interests. Trump's support for Oracle and potential buyers adds to the drama.

Merck and Eisai report mixed results from LEAP-015 trial of Keytruda and Lenvima in HER2-negative gastroesophageal cancer treatment.

Perspective Therapeutics shares interim results for [212Pb]VMT-α-NET trial, showing promising safety, stable disease cases, and anti-tumor activity.

JP Morgan analyst maintains Overweight rating on Qualcomm, as Samsung's flagship S25 uses Snapdragon chips, increasing Qualcomm's revenue and EPS.